Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Shandong Xinhua Pharmaceutical Company Limited Class H ( (HK:0719) ) has shared an update.
Shandong Xinhua Pharmaceutical Company Limited has announced a board meeting scheduled for October 24, 2025, to review and approve the unaudited financial results for the nine months ending September 30, 2025. This meeting is significant for stakeholders as it will provide insights into the company’s financial performance and potential strategic directions.
More about Shandong Xinhua Pharmaceutical Company Limited Class H
Shandong Xinhua Pharmaceutical Company Limited is a joint stock company based in the People’s Republic of China, primarily operating in the pharmaceutical industry. The company focuses on the production and distribution of pharmaceutical products.
Average Trading Volume: 6,549,300
Technical Sentiment Signal: Buy
Current Market Cap: HK$9.78B
Learn more about 0719 stock on TipRanks’ Stock Analysis page.